HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshitomo Morinaga Selected Research
Yoshitomo Morinaga Research Topics
Disease
38
Infections
10/2023 - 01/2005
23
Pneumonia (Pneumonitis)
01/2024 - 05/2007
15
COVID-19
01/2024 - 12/2020
7
Communicable Diseases (Infectious Diseases)
08/2023 - 05/2011
6
Abscess
05/2024 - 10/2006
6
Respiratory Tract Infections (Respiratory Tract Infection)
08/2023 - 12/2008
4
Ventilator-Associated Pneumonia
01/2017 - 08/2012
4
Sepsis (Septicemia)
09/2016 - 10/2006
3
Bacteremia
10/2023 - 01/2016
3
Pulmonary Aspergillosis
04/2022 - 09/2012
3
Human Influenza (Influenza)
05/2021 - 01/2014
3
Septic Shock (Toxic Shock Syndrome)
01/2020 - 02/2010
3
Healthcare-Associated Pneumonia
11/2019 - 02/2013
3
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2016 - 04/2012
3
Cystic Fibrosis (Mucoviscidosis)
05/2011 - 01/2005
2
Bacterial Pneumonia
10/2023 - 10/2010
2
Clostridium Infections
11/2022 - 11/2018
2
Asthma (Bronchial Asthma)
04/2022 - 12/2009
2
Respiratory Insufficiency (Respiratory Failure)
01/2022 - 03/2014
2
Vesicular Stomatitis
01/2022 - 12/2021
2
Hypoxia (Hypoxemia)
01/2022 - 03/2014
2
Fever (Fevers)
05/2021 - 04/2007
2
Periodontitis
01/2020 - 04/2013
2
Chronic Obstructive Pulmonary Disease (COPD)
09/2019 - 10/2010
2
Liver Diseases (Liver Disease)
04/2019 - 01/2012
2
Body Weight (Weight, Body)
01/2017 - 02/2010
2
Neoplasms (Cancer)
08/2016 - 01/2012
2
Pneumococcal Pneumonia
02/2014 - 12/2011
2
Diffuse panbronchiolitis
01/2012 - 10/2010
2
Respiratory Tract Diseases (Respiratory Tract Disease)
05/2011 - 10/2010
2
Bronchiectasis
05/2011 - 01/2005
1
Febrile Neutropenia
05/2024
1
Breakthrough Infections
01/2024
1
Fatty Liver
11/2023
1
Insulin Resistance
11/2023
1
Weight Gain
11/2023
1
Obesity
11/2023
1
Viral Pneumonia
10/2023
1
Allergic Bronchopulmonary Aspergillosis
04/2022
1
Severe Acute Respiratory Syndrome
12/2021
1
Virus Diseases (Viral Diseases)
12/2021
Drug/Important Bio-Agent (IBA)
23
Anti-Bacterial Agents (Antibiotics)
IBA
10/2021 - 01/2005
8
Vancomycin
FDA Link
Generic
11/2022 - 10/2006
7
Azithromycin (Zithromax)
FDA Link
Generic
05/2021 - 03/2008
7
Macrolides
IBA
09/2019 - 12/2009
5
Carbapenems (Carbapenem Antibiotics)
IBA
04/2019 - 06/2008
4
Anti-Infective Agents (Microbicides)
IBA
08/2023 - 10/2007
4
Cytokines
IBA
04/2022 - 01/2011
4
Quinolones
IBA
11/2019 - 10/2007
4
Meropenem (Merrem)
FDA Link
Generic
09/2016 - 12/2008
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
05/2024 - 10/2006
3
Antigens
IBA
02/2023 - 04/2007
3
Vaccines
IBA
09/2022 - 12/2021
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2022 - 02/2013
3
Neutralizing Antibodies
IBA
01/2022 - 01/2021
3
Clarithromycin (Biaxin)
FDA Link
Generic
01/2012 - 03/2008
2
C-Reactive Protein
IBA
05/2024 - 12/2020
2
Interleukin-6 (Interleukin 6)
IBA
01/2024 - 01/2022
2
Lipids
IBA
11/2023 - 05/2021
2
Biomarkers (Surrogate Marker)
IBA
10/2023 - 04/2012
2
Leukocidins (Leukocidin)
IBA
10/2023 - 01/2020
2
RNA (Ribonucleic Acid)
IBA
01/2022 - 07/2021
2
Interferon Type I
IBA
01/2022 - 01/2022
2
sitafloxacin
IBA
11/2019 - 09/2009
2
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 02/2017
2
Daptomycin
FDA Link
01/2019 - 06/2013
2
tedizolid
IBA
09/2017 - 09/2016
2
Levofloxacin (Levaquin)
FDA Link
03/2017 - 02/2013
2
Agar
IBA
02/2017 - 11/2008
2
Fluoroquinolones
IBA
01/2017 - 10/2010
2
beta-Lactamases (beta-Lactamase)
IBA
01/2017 - 06/2008
2
arbekacin
IBA
01/2017 - 04/2012
2
Linezolid (Zyvox)
FDA Link
09/2016 - 11/2009
2
biapenem (L 627)
IBA
09/2013 - 08/2012
2
Mucins
IBA
04/2013 - 10/2010
2
Tobramycin (Nebcin)
FDA Link
Generic
05/2011 - 01/2005
2
Panton-Valentine leukocidin
IBA
02/2010 - 11/2009
1
ORALIT (ORS)
IBA
05/2024
1
isoxanthohumol
IBA
11/2023
1
Flavonoids
IBA
11/2023
1
Dietary Fats (Dietary Fat)
IBA
11/2023
1
Glucose (Dextrose)
FDA Link
Generic
11/2023
1
Polyphenols
IBA
11/2023
1
Interleukin-10 (Interleukin 10)
IBA
10/2023
1
Trypsin
IBA
01/2023
1
Peptide Hydrolases (Proteases)
FDA Link
01/2023
1
Fidaxomicin
IBA
11/2022
1
Interleukin-33
IBA
04/2022
1
Interleukins
IBA
04/2022
1
Luciferases
IBA
01/2022
1
casirivimab and imdevimab drug combination
IBA
01/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
mRNA Vaccines
IBA
12/2021
1
Enzymes
IBA
12/2021
1
Immunosorbents
IBA
12/2021
Therapy/Procedure
16
Therapeutics
12/2020 - 10/2006
6
Drug Therapy (Chemotherapy)
08/2023 - 10/2012
2
Aftercare (After-Treatment)
01/2022 - 02/2010
2
Oral Hygiene (Dental Hygiene)
01/2020 - 02/2014
1
Long-Term Care
10/2023